Stryker Stock Revenue Per Share

SYK Stock

USD 364.60 7.46 2.09%

Stryker fundamentals help investors to digest information that contributes to Stryker's financial success or failures. It also enables traders to predict the movement of Stryker Stock. The fundamental analysis module provides a way to measure Stryker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stryker stock.

		Last Reported	Projected for Next Year
	Revenue Per Share	54.00	56.70

Revenue Per Share is expected to rise to 56.70 this year.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Stryker Company Revenue Per Share Analysis

Stryker's Revenue per Share is a ratio of total revenue earned per one share of common stock over a single fiscal year. It is calculated by dividing sales revenue earned over 12 months by the average number of outstanding shares. Revenue used in the calculation of this ratio is typically recorded when cash or cash equivalents are exchanged for services or goods.

Current Stryker Revenue Per Share

56.7

Most of Stryker's fundamental indicators, such as Revenue Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Stryker Revenue Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Stryker is extremely important. It helps to project a fair market value of Stryker Stock properly, considering its historical fundamentals such as Revenue Per Share. Since Stryker's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Stryker's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Stryker's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Short Term Investments	Current Deferred Revenue	Good Will	Common Stock	Long Term Debt	Property Plant Equipment	Net Tangible Assets	Capital Surpluse	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.94	0.98	0.99	0.99	0.87	0.74	0.95	0.94	-0.5	0.76	0.98	0.62	0.94	0.98	-0.91	0.88	-0.97	0.88	-0.69	0.6	-0.52	0.41	0.11	0.66
Total Stockholder Equity	0.97		0.88	1.0	0.99	0.93	0.92	0.76	0.87	0.95	-0.37	0.69	0.93	0.7	0.85	0.95	-0.81	0.84	-0.91	0.78	-0.59	0.65	-0.56	0.38	0.03	0.71
Net Debt	0.94	0.88		0.89	0.91	0.96	0.67	0.64	0.92	0.92	-0.6	0.85	0.98	0.38	0.96	0.95	-0.94	0.87	-0.97	0.91	-0.77	0.53	-0.6	0.34	0.05	0.63
Retained Earnings	0.98	1.0	0.89		0.99	0.95	0.91	0.76	0.9	0.95	-0.41	0.7	0.95	0.69	0.87	0.96	-0.84	0.85	-0.93	0.81	-0.61	0.65	-0.55	0.4	0.05	0.7
Net Receivables	0.99	0.99	0.91	0.99		0.96	0.89	0.76	0.91	0.95	-0.47	0.72	0.96	0.64	0.89	0.97	-0.86	0.87	-0.94	0.83	-0.65	0.64	-0.55	0.37	0.09	0.68
Total Liab	0.99	0.93	0.96	0.95	0.96		0.82	0.71	0.97	0.9	-0.58	0.78	0.98	0.54	0.98	0.98	-0.96	0.89	-0.97	0.92	-0.74	0.55	-0.47	0.42	0.16	0.6
Total Current Assets	0.87	0.92	0.67	0.91	0.89	0.82		0.68	0.77	0.76	-0.11	0.54	0.76	0.86	0.69	0.8	-0.66	0.69	-0.75	0.63	-0.46	0.56	-0.31	0.41	0.17	0.55
Short Term Debt	0.74	0.76	0.64	0.76	0.76	0.71	0.68		0.59	0.78	-0.43	0.48	0.74	0.36	0.59	0.77	-0.6	0.64	-0.67	0.52	-0.39	0.95	-0.54	0.6	-0.15	0.78
Intangible Assets	0.95	0.87	0.92	0.9	0.91	0.97	0.77	0.59		0.81	-0.6	0.7	0.93	0.56	0.98	0.94	-0.97	0.86	-0.93	0.93	-0.78	0.43	-0.4	0.37	0.19	0.47
Accounts Payable	0.94	0.95	0.92	0.95	0.95	0.9	0.76	0.78	0.81		-0.5	0.76	0.96	0.47	0.84	0.94	-0.8	0.85	-0.93	0.77	-0.59	0.7	-0.69	0.33	-0.08	0.79
Short Term Investments	-0.5	-0.37	-0.6	-0.41	-0.47	-0.58	-0.11	-0.43	-0.6	-0.5		-0.4	-0.61	0.17	-0.68	-0.61	0.68	-0.57	0.6	-0.65	0.53	-0.33	0.26	-0.26	-0.19	-0.32
Current Deferred Revenue	0.76	0.69	0.85	0.7	0.72	0.78	0.54	0.48	0.7	0.76	-0.4		0.79	0.17	0.79	0.78	-0.69	0.68	-0.82	0.75	-0.69	0.42	-0.37	0.35	0.29	0.54
Good Will	0.98	0.93	0.98	0.95	0.96	0.98	0.76	0.74	0.93	0.96	-0.61	0.79		0.46	0.95	0.98	-0.93	0.9	-0.98	0.89	-0.71	0.61	-0.61	0.38	0.03	0.69
Common Stock	0.62	0.7	0.38	0.69	0.64	0.54	0.86	0.36	0.56	0.47	0.17	0.17	0.46		0.42	0.5	-0.44	0.52	-0.46	0.43	-0.25	0.25	-0.25	0.23	0.05	0.31
Long Term Debt	0.94	0.85	0.96	0.87	0.89	0.98	0.69	0.59	0.98	0.84	-0.68	0.79	0.95	0.42		0.95	-0.97	0.87	-0.96	0.95	-0.79	0.43	-0.41	0.36	0.23	0.5
Property Plant Equipment	0.98	0.95	0.95	0.96	0.97	0.98	0.8	0.77	0.94	0.94	-0.61	0.78	0.98	0.5	0.95		-0.92	0.88	-0.97	0.88	-0.74	0.65	-0.53	0.45	0.13	0.69
Net Tangible Assets	-0.91	-0.81	-0.94	-0.84	-0.86	-0.96	-0.66	-0.6	-0.97	-0.8	0.68	-0.69	-0.93	-0.44	-0.97	-0.92		-0.86	0.93	-0.94	0.76	-0.42	0.48	-0.38	-0.09	-0.5
Capital Surpluse	0.88	0.84	0.87	0.85	0.87	0.89	0.69	0.64	0.86	0.85	-0.57	0.68	0.9	0.52	0.87	0.88	-0.86		-0.9	0.94	-0.73	0.49	-0.61	0.39	0.14	0.65
Accumulated Depreciation	-0.97	-0.91	-0.97	-0.93	-0.94	-0.97	-0.75	-0.67	-0.93	-0.93	0.6	-0.82	-0.98	-0.46	-0.96	-0.97	0.93	-0.9		-0.9	0.72	-0.52	0.56	-0.27	-0.1	-0.59
Long Term Debt Total	0.88	0.78	0.91	0.81	0.83	0.92	0.63	0.52	0.93	0.77	-0.65	0.75	0.89	0.43	0.95	0.88	-0.94	0.94	-0.9		-0.82	0.36	-0.44	0.41	0.29	0.5
Long Term Investments	-0.69	-0.59	-0.77	-0.61	-0.65	-0.74	-0.46	-0.39	-0.78	-0.59	0.53	-0.69	-0.71	-0.25	-0.79	-0.74	0.76	-0.73	0.72	-0.82		-0.3	0.34	-0.33	-0.32	-0.35
Short Long Term Debt	0.6	0.65	0.53	0.65	0.64	0.55	0.56	0.95	0.43	0.7	-0.33	0.42	0.61	0.25	0.43	0.65	-0.42	0.49	-0.52	0.36	-0.3		-0.51	0.64	-0.21	0.8
Cash And Equivalents	-0.52	-0.56	-0.6	-0.55	-0.55	-0.47	-0.31	-0.54	-0.4	-0.69	0.26	-0.37	-0.61	-0.25	-0.41	-0.53	0.48	-0.61	0.56	-0.44	0.34	-0.51		-0.12	0.61	-0.7
Net Invested Capital	0.41	0.38	0.34	0.4	0.37	0.42	0.41	0.6	0.37	0.33	-0.26	0.35	0.38	0.23	0.36	0.45	-0.38	0.39	-0.27	0.41	-0.33	0.64	-0.12		0.2	0.64
Net Working Capital	0.11	0.03	0.05	0.05	0.09	0.16	0.17	-0.15	0.19	-0.08	-0.19	0.29	0.03	0.05	0.23	0.13	-0.09	0.14	-0.1	0.29	-0.32	-0.21	0.61	0.2		-0.2
Capital Stock	0.66	0.71	0.63	0.7	0.68	0.6	0.55	0.78	0.47	0.79	-0.32	0.54	0.69	0.31	0.5	0.69	-0.5	0.65	-0.59	0.5	-0.35	0.8	-0.7	0.64	-0.2

Click cells to compare fundamentals

Stryker Revenue Per Share Historical Pattern

Today, most investors in Stryker Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Stryker's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Stryker revenue per share as a starting point in their analysis.

Stryker Revenue Per Share

Timeline

Revenue per share does not take into account any of company expenses and is helpful only when comparing relative sale figures within a given industry.

Competition

Predict Stryker

Revenue Per Share Over Time

Stryker Common Stock Shares Outstanding

Common Stock Shares Outstanding

426.32 Million

At this time, Stryker's Common Stock Shares Outstanding is quite stable compared to the past year.

Stryker Revenue Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its Revenue Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.

Stryker is currently under evaluation in revenue per share category among its peers.

Stryker ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Stryker's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Stryker's managers, analysts, and investors.

Environmental

Governance

Social

Stryker Fundamentals

	Return On Equity	0.19
	Return On Asset	0.0711
	Profit Margin	0.16 %
	Operating Margin	0.22 %
	Current Valuation	149.79 B
	Shares Outstanding	381.22 M
	Shares Owned By Insiders	5.37 %
	Shares Owned By Institutions	80.47 %
	Number Of Shares Shorted	4.24 M
	Price To Earning	63.07 X
	Price To Book	6.90 X
	Price To Sales	6.33 X
	Revenue	20.5 B
	Gross Profit	11.65 B
	EBITDA	4.93 B
	Net Income	3.17 B
	Cash And Equivalents	1.84 B
	Cash Per Share	2.98 X
	Total Debt	12.99 B
	Debt To Equity	0.88 %
	Current Ratio	2.00 X
	Book Value Per Share	52.85 X
	Cash Flow From Operations	3.71 B
	Short Ratio	2.90 X
	Earnings Per Share	9.33 X
	Price To Earnings To Growth	2.55 X
	Target Price	406.6
	Number Of Employees	52 K
	Beta	0.92
	Market Capitalization	138.99 B
	Total Asset	39.91 B
	Retained Earnings	16.77 B
	Working Capital	4.6 B
	Current Asset	1.15 B
	Current Liabilities	707.5 M
	Annual Yield	0.01 %
	Five Year Return	1.07 %
	Net Asset	39.91 B
	Last Dividend Paid	3.2

About Stryker Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:

How To Invest In Stryker

Details

Is Stryker Stock a good investment?

Details

What is Stryker's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Stryker Piotroski F Score and Stryker Altman Z Score analysis.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.2

Dividend Share

3.2

Earnings Share

9.33

Revenue Per Share

57.728

Quarterly Revenue Growth

0.119

The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stryker Stock Revenue Per Share

Stryker Company Revenue Per Share Analysis

Current Stryker Revenue Per Share

Stryker Revenue Per Share Driver Correlations

Stryker Revenue Per Share Historical Pattern

Stryker Common Stock Shares Outstanding

Common Stock Shares Outstanding

426.32 Million

Stryker Revenue Per Share Peer Comparison

Stryker ESG Sustainability

Stryker Fundamentals

About Stryker Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY